Back to DE D. E. Shaw & Co., Inc.

CRSPCRSP
Showing 3 of 24 quarters

Position history for DED. E. Shaw & Co., Inc.'s holdings in CRISPR THERAPEUTICS AG

D. E. Shaw & Co., Inc. holds 893,812 shares of CRSP (CRISPR THERAPEUTICS AG), worth $48.7M as of 2026-Q2. This is a new position. CRSP represents 0.0% of D. E. Shaw & Co., Inc.'s portfolio.

Current Value

$48.7M

Current Shares

893,812

Total Value Change

+$47.4M

Total Shares Change

+864,447

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
893,812
-
$48.7M0.0%$54.54
41
2024-Q4
Exited
0
-100.0%
$00.0%$38.65
0
2024-Q3
Increased
29,365
+4.2%
$1.4M0.0%$47.32
27

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used